title: Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials.
authors.forename: Jorge
authors.initials: J
authors.lastname: Duconge
authors.forename: Carmen L
authors.initials: CL
authors.lastname: Cadilla
authors.forename: Richard L
authors.initials: RL
authors.lastname: Seip
authors.forename: Gualberto
authors.initials: G
authors.lastname: Ruaño
mesh_terms: D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D064417:Vitamin K Epoxide Reductases / Q000235:genetics*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D001189:Aryl Hydrocarbon Hydroxylases; D064417:Vitamin K Epoxide Reductases